Does ADALIMUMAB Cause Peripheral t-cell lymphoma unspecified? 9 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Peripheral t-cell lymphoma unspecified have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.0% of all adverse event reports for ADALIMUMAB.
9
Reports of Peripheral t-cell lymphoma unspecified with ADALIMUMAB
0.0%
of all ADALIMUMAB reports
4
Deaths
4
Hospitalizations
How Dangerous Is Peripheral t-cell lymphoma unspecified From ADALIMUMAB?
Of the 9 reports, 4 (44.4%) resulted in death, 4 (44.4%) required hospitalization.
Is Peripheral t-cell lymphoma unspecified Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause Peripheral t-cell lymphoma unspecified?
ROMIDEPSIN (102)
BRENTUXIMAB VEDOTIN (89)
CYCLOPHOSPHAMIDE (65)
DOXORUBICIN (64)
PREDNISONE (53)
VINCRISTINE (38)
METHOTREXATE (37)
PREDNISOLONE (34)
RITUXIMAB (32)
ETOPOSIDE (26)
Which ADALIMUMAB Alternatives Have Lower Peripheral t-cell lymphoma unspecified Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB